Wang Chunxia, Zheng Jianli, Zhao Yilin, Liu Tiantian, Zhang Yucai
Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, 200062, Shanghai, China.
Laboratory of Critical Care Translational Medicine, Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, 200062, Shanghai, China.
Heliyon. 2024 Mar 16;10(6):e27563. doi: 10.1016/j.heliyon.2024.e27563. eCollection 2024 Mar 30.
Oxygen and hemodynamic management are important for providing a sufficient adequate oxygen-containing blood to the organs for septic patients. In present study, we aimed to explore the application of sequential respiratory support (SRS) and the association of SRS with the outcome of septic patients who needed continuous renal replacement therapy (CRRT).
We extracted the medical information of septic patients who received CRRT within 24 h of intensive care unit (ICU) admission from the MIMIC-III v1.4. SRS was defined as receiving firstly oxygen therapy followed by mechanical ventilation (MV) within 24 h of admission to ICU. The was performed to compare the differences in clinical characteristics and outcomes of patients with or without SRS. Finally, we developed regression models to analyze the effects of SRS on hospital mortality.
A total of 181 patients entered in this study, and there were 80 patients undergoing MV including SRS group (n = 61) and non-SRS group (n = 19). In the multivariate regression, the value of SRS was associated with the lower risk of hospital mortality adjusted by minimum systolic BP (SBP), maximum lactate, vasopressor use, and sequential organ failure assessment (SOFA) score or Logistic Organ Dysfunction System (LODS) scores within the first 24 h of ICU stay. After adjusted by SBP, maximum lactate, vasopressor use, SOFA, and LODS, there were 31 patients in SRS group with a and 18 cases in non-SRS group, displaying a significantly lower hospital mortality in SRS group than that in patients without S (19.4 % 83.3 %, < 0.001). In addition, age, qSOFA, necessitating the administration of vasopressor, and duration of vasopressor were significantly correlated with the hospital mortality in septic patients undergoing CRRT and SRS.
Receiving SRS within the first 24 h upon admission to the ICU was independently associated with the hospital mortality in patient with sepsis undergoing CRRT, and patients who were directly received MV had a high risk of death.
对于脓毒症患者,氧疗和血流动力学管理对于为各器官提供充足的含氧血液至关重要。在本研究中,我们旨在探讨序贯呼吸支持(SRS)的应用以及SRS与需要持续肾脏替代治疗(CRRT)的脓毒症患者预后的相关性。
我们从MIMIC-III v1.4中提取了在重症监护病房(ICU)入院后24小时内接受CRRT的脓毒症患者的医疗信息。SRS定义为在入住ICU后24小时内首先接受氧疗,随后接受机械通气(MV)。进行比较有或没有SRS的患者的临床特征和预后的差异。最后,我们建立回归模型以分析SRS对医院死亡率的影响。
本研究共纳入181例患者,其中80例接受MV,包括SRS组(n = 61)和非SRS组(n = 19)。在多变量回归中,SRS的值与ICU住院前24小时内通过最低收缩压(SBP)、最高乳酸水平、血管升压药使用情况以及序贯器官衰竭评估(SOFA)评分或逻辑器官功能障碍系统(LODS)评分调整后的较低医院死亡风险相关。在通过SBP、最高乳酸水平、血管升压药使用情况、SOFA和LODS进行调整后,SRS组有31例患者死亡,非SRS组有18例患者死亡,SRS组的医院死亡率显著低于无SRS的患者(19.4%对83.3%,P<0.001)。此外,年龄、快速序贯器官衰竭评估(qSOFA)、需要使用血管升压药以及血管升压药使用持续时间与接受CRRT和SRS的脓毒症患者的医院死亡率显著相关。
入住ICU后24小时内接受SRS与接受CRRT的脓毒症患者的医院死亡率独立相关,而直接接受MV的患者死亡风险较高。